Search results
Novo Nordisk’s Wegovy approved in China as weight-loss drug race heats up
Semafor· 7 days agoThe market for weight-loss drugs is currently a ‘duopoly’ Sources: Semafor, Nature The weight-loss...
Novo to spend $4B on US plant, adding to obesity drug production push
BioPharma Dive· 7 days agoThe planned facility in North Carolina is Novo’s latest multibillion-dollar investment in the...
BMS expands Krazati’s FDA label to include colorectal cancer
Clinical Trials Arena· 7 days agoThe drug’s approved use will be in combination with Eli Lilly’s epidermal growth factor receptor...
Cape League Power Rankings: Potent offense powers Hyannis Harbor Hawks to top spot
Cape Cod Times· 7 days agoFresno State’s Tristan Gray has 10 hits and six RBIs for Wareham, which has seven players with at...
Novo Nordisk's Wegovy weight-loss drug approved in China - ET HealthWorld | Pharma
The Economic Times· 7 days agoShanghai: Novo Nordisk said on Tuesday its popular weight-loss drug Wegovy has been approved in...
ADA 2024: Altimmune’s GLP-1 drug shows weight loss potential
Clinical Trials Arena· 7 days agoAlongside Altimmune’s announcement, companies such as Novo Nordisk, Eli Lilly, and other pharma...